Cargando…
Correction: Decline in Clinical Efficacy of Oral Miltefosine in Treatment of Post Kala-azar Dermal Leishmaniasis (PKDL) in India
Autores principales: | Ramesh, V., Singh, Ruchi, Avishek, Kumar, Verma, Aditya, Deep, Deepak Kumar, Verma, Sandeep, Salotra, Poonam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4671613/ https://www.ncbi.nlm.nih.gov/pubmed/26642203 http://dx.doi.org/10.1371/journal.pntd.0004289 |
Ejemplares similares
-
Decline in Clinical Efficacy of Oral Miltefosine in Treatment of Post Kala-azar Dermal Leishmaniasis (PKDL) in India
por: Ramesh, V., et al.
Publicado: (2015) -
Foxp3 and IL-10 Expression Correlates with Parasite Burden in Lesional Tissues of Post Kala Azar Dermal Leishmaniasis (PKDL) Patients
por: Katara, Gajendra Kumar, et al.
Publicado: (2011) -
Evidence for Involvement of Th17 Type Responses in Post Kala Azar Dermal Leishmaniasis (PKDL)
por: Katara, Gajendra Kumar, et al.
Publicado: (2012) -
Drug Susceptibility in Leishmania Isolates Following Miltefosine Treatment in Cases of Visceral Leishmaniasis and Post Kala-Azar Dermal Leishmaniasis
por: Bhandari, Vasundhra, et al.
Publicado: (2012) -
The immunology of post-kala-azar dermal leishmaniasis (PKDL)
por: Zijlstra, Eduard E.
Publicado: (2016)